Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agenus Inc (NASDAQ:AGEN)

4.33
Delayed Data
As of Oct 20
 -0.14 / -3.13%
Today’s Change
3.20
Today|||52-Week Range
5.98
+5.10%
Year-to-Date
No recent news for Agenus Inc.

Today’s Trading

Previous close4.47
Today’s open4.52
Day’s range4.25 - 4.52
Volume1,259,332
Average volume (3 months)1,113,846
Market cap$376.7M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-29.20%
Earnings growth (this year)+22.83%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-9.04%
P/E ratioNM
Price/Sales15.89
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RIGLRigel Pharmaceutical...-0.08-2.02%
EDGEEdge Therapeutics In...+0.20+1.95%
NVAXNovavax Inc-0.01-0.94%
BTXBioTime Inc-0.09-3.30%
Data as of 7:59pm ET, 10/20/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$22.6M
Annual profit (last year)-$127.0M
Net profit margin-562.59%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Garo H. Armen
Principal Accounting Officer &
VP-Finance
Christine M. Klaskin
Corporate headquarters
Lexington, Massachusetts

Forecasts